Macrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing

Hypertension - Tập 73 Số 1 - Trang 102-111 - 2019
Daniela Fraccarollo1, Svenja Thomas1, Claus‐Jürgen Scholz2, Denise Hilfiker‐Kleiner1, Paolo Galuppo1, Johann Bauersachs1
1From the Department of Cardiology and Angiology, Hannover Medical School, Germany (D.F., S.T., D.H.-K., P.G., J.B.)
2Core Unit SysMed, University of Würzburg, Germany (C.-J.S.).

Tóm tắt

Myocardial infarction (MI) is a major cause of death worldwide. Here, we identify the macrophage MR (mineralocorticoid receptor) as a crucial pathogenic player in cardiac wound repair after MI. Seven days after left coronary artery ligation, mice with myeloid cell–restricted MR deficiency compared with WT (wild type) controls displayed improved cardiac function and remodeling associated with enhanced infarct neovascularization and scar maturation. Gene expression profiling of heart-resident and infarct macrophages revealed that MR deletion drives macrophage differentiation in the ischemic microenvironment toward a phenotype outside the M1/M2 paradigm, with regulation of multiple interrelated factors controlling wound healing and tissue repair. Mechanistic and functional data suggest that inactivation of the macrophage MR promotes myocardial infarct healing through enhanced efferocytosis of neutrophils, the suppression of free radical formation, and the modulation of fibroblast activation state. Crucially, targeted delivery of MR antagonists to macrophages, with a single administration of RU28318 or eplerenone-containing liposomes at the onset of MI, improved the healing response and protected against cardiac remodeling and functional deterioration, offering an effective and unique therapeutic strategy for cardiac repair.

Từ khóa


Tài liệu tham khảo

10.1093/cvr/cvs109

10.1096/fj.201700317R

10.1161/CIRCULATIONAHA.118.033665

10.1161/CIRCRESAHA.116.303577

10.1136/heartjnl-2018–312950

10.1136/heartjnl-2018–313371

10.1161/CIRCULATIONAHA.110.983023

10.1161/HYPERTENSIONAHA.107.100941

10.1161/CIRCULATIONAHA.104.503706

10.1161/01.CIR.0000138973.55605.38

10.1073/pnas.1015623108

10.3389/fphys.2015.00107

10.1161/HYPERTENSIONAHA.109.131110

10.1172/JCI41080

10.1172/JCI98215

10.1038/nm.4428

10.1016/j.celrep.2018.03.029

10.1016/j.celrep.2017.12.072

10.1096/fj.15-274266

10.1177/1074248414534916

10.4049/jimmunol.1601520

10.1038/ncomms12260

10.1172/JCI85782

10.12703/P6-13

10.1681/ASN.2010121301

10.1016/j.immuni.2014.01.006

10.1096/fj.12-214049

10.1074/jbc.M116.739243

10.1093/cvr/cvy092

10.3389/fimmu.2017.01319

10.3389/fimmu.2014.00402

10.1161/01.CIR.0000127949.05756.9D

10.1186/1755-1536-6-5

10.1161/HYPERTENSIONAHA.117.09791

10.1172/JCI121079

10.1001/jamainternmed.2018.0850

10.1001/jamainternmed.2018.1940

10.1016/j.jacc.2011.04.049

10.1159/000480652

10.1016/j.kint.2017.12.016

10.1681/ASN.2012111094

Thông tin
Thông tin xuất bản

Hypertension

Tập 73 Số 1

102-111

Thông tin tác giả